<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Maillard I</dc:creator>
  <dc:creator>Schweizer V</dc:creator>
  <dc:creator>Broccard A</dc:creator>
  <dc:creator>Duscher A</dc:creator>
  <dc:creator>Liaudet L</dc:creator>
  <dc:creator>Schaller MD</dc:creator>
  <dc:date>2000</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Paradoxical vocal cord movement (PVCM) is characterized by paradoxical adduction of the vocal cords during inspiration and/or expiration. Patients with severe forms of PVCM can present with acute dyspnea. In this article, we describe a patient with severe PVCM who had required tracheal intubation or tracheostomy at multiple occasions and who presented with acute hypercapnic respiratory failure. Using sedation and intralaryngeal injection of botulinum toxin type A, we could avoid more invasive intervention. Our observation shows that botulinum toxin type A should be considered in the acute care setting for severe PVCM.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/277839</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1378/chest.118.3.874</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/10988221</dc:relation>
  <dc:source>Chest. - 2000</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Botulinum Toxins, Type A</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Contraindications</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Intubation, Intratracheal</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Laryngeal Diseases</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Neuromuscular Agents</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Respiratory Distress Syndrome, Adult</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Tracheostomy</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Vocal Cords</dc:subject>
  <dc:title xmlns:ns12="xml" ns12:lang="en">Use of botulinum toxin type A to avoid tracheal intubation or tracheostomy in severe paradoxical vocal cord movement.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
